Nerofe Uses, Dosage, Side Effects and more
Nerofe is under investigation in clinical trial NCT03059615 (A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS).
| Trade Name | Nerofe |
| Generic | Nerofe |
| Type | |
| Formula | C96H129N21O20 |
| Weight | Average: 1897.215 Monoisotopic: 1895.972275638 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
